Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2001, p. 53-56, Vol. 39, No. 1
Medical Microbiology Division, Department of
Pathology, University of Iowa College of Medicine, Iowa City, Iowa
52242
Received 21 August 2000/Returned for modification 10 October
2000/Accepted 18 October 2000
The Vitek automated susceptibility testing system with a modified
Gram-Positive Susceptibility (GPS) 106 Card (bioMerieux Vitek, Inc.,
Hazelwood, Mo.) and a rapid slide latex agglutination test
(MRSA-Screen; Denka Seiken Co., Ltd., Tokyo, Japan) were evaluated for
their ability to detect oxacillin resistance in Staphylococcus
aureus. The oxacillin-salt agar screen (OS) test, the reference
broth microdilution method, and the detection of the mecA
gene by PCR were compared with the commercial products. A total of 200 contemporary (1999) bloodstream infection isolates were collected from
the SENTRY Antimicrobial Surveillance Program, representing diverse
geographic areas throughout the world. Among the 99 mecA-positive isolates, 3 isolates were found negative by
the MRSA-Screen. Another two isolates did not grow on OS plates and had
MICs of 0.5 and 2 µg/ml with the Vitek GPS card. All 101 mecA-negative isolates were also found negative by the
MRSA-Screen and were categorized as susceptible by the GPS card.
Overall, the MRSA-Screen, GPS card, and OS test had sensitivities of
96.9, 98.0, and 98.0% and specificities of 100.0, 100.0, and 98.0%, respectively. MRSA-Screen was a rapid (
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.1.53-56.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Comparison of the Vitek Gram-Positive
Susceptibility 106 Card and the MRSA-Screen Latex Agglutination Test
for Determining Oxacillin Resistance in Clinical Bloodstream Isolates
of Staphylococcus aureus

15 min) and simple test to
perform, and the GPS card provided results in <8 h. Both methods were
sensitive and specific for detecting staphylococcal oxacillin resistance in the clinical microbiology laboratory.
*
Corresponding author. Present address: 345 Beaver Kreek
Centre, Suite A, North Liberty, IA 52317. Phone: (319) 665-3370. Fax: (319) 665-3371.
Present address: Department of Clinical Pathology, Kinki University
School of Medicine, Ohnohigashi, Osakasayama, Osaka, Japan 589-8511.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|